LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Shares of On Assignment Inc. rose more than 7 percent on Thursday, after the staffing company reported strong fourth quarter results.
Herbalife Ltd. on Tuesday reported a 10 percent rise in fourth quarter profit and raised its guidance based on strong sales of its weight loss products.
MannKind Corp. on Tuesday reported another quarterly loss, but shares held steady as investors look forward to possible FDA approval of the company’s inhalable insulin in April.
Arrowhead Research Corp. on Tuesday announced plans to sell an undisclosed number of common shares to raise money for clinical drug trials.
INSURANCE: L.A. Care adds HealthCare physicians to Covered California plan.
L.A. Care Health Plan has added Los Angeles County’s largest operator of physician practices to its plan on the California health exchange.
Shares of West Hollywood marijuana services provider Medbox Inc., jumped 27 percent on Friday after U.S. officials took steps that could lead to banks being able serve marijuana-selling businesses.
J2 Global Inc. shares jumped 19 percent in after-hours trading Thursday after the Hollywood company reported better-than-expected adjusted profit and gave optimistic future guidance. Oaktree Capital Group on Thursday said its fourth-quarter profit rose 65 percent. VCA Antech Inc. said that it moved to profit in its fourth quarter as revenue from its veterinary clinics and laboratories grew.
Puma Biotechnology Inc. early Tuesday priced a public offering of 979,592 common shares at $122.50 a share, 2.6 percent below its later closing price.
Health Net Inc. reported fourth quarter earnings Tuesday that missed Wall Street expectations, as the company saw a bump in costs associated with the new Affordable Care Act.
Shares of Molina Healthcare Inc. fell more than 5 percent on Tuesday, a day after the Medicaid managed care provider said it moved to a loss in the fourth quarter on increased expenses and a retroactive rate reduction in Washington state.
Clinical trials will begin this fall for an advanced melanoma drug developed in a collaboration of Amgen Inc. and Merck & Co. Inc.
Herbalife announced early Monday it is increasing its share buyback program by $500 million, to $1.5 billion. The buyback is being financed by selling $1 billion of convertible bonds.
West L.A. biotech firm CytRx Corp. has announced a $75 million public stock offering.
Amgen on Tuesday reported fourth-quarter results that beat earnings expectations on a pro forma basis that excludes acquisition costs.
Iron Neck exercises muscles to help protect head in collisions.
Sports: Mission Competition’s Iron Neck exercise device looks to head off football injuries.